EUVIMEDEUVIMED entdecken
Crossref

Steroidal Inhibitors of CYP17A1 as a Template For Novel Anti-Cancer Agents Development

A.S. Latysheva, A.Yu. Misharin

Biomedical Chemistry: Research and Methods · 2018

DOI: 10.18097/bmcrm00020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chemistry: Research and Methods, 2018. Verfasst von A.S. Latysheva und 1 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 81 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review deals with studies of researches of novel CYP17A1 steroidal inhibitors and relative compounds published over the last ten years. The review contains six chapters in which novel targets of well-known CYP17A1 inhibirors (abiraterone and galeterone), anti-cancer and anti-proliferative activities of them major metabolites and new synthetic analogs, and in addition another nitrogen-containing androstane and pregnane derivatives are considered. In the review 354 structures of novel steroid derivatives and them anti-cancer efficiency data are considered. Analysis of the literature data allows us to consider steroidal inhibitors of CYP17A1 as multi-target anti-cancer agents with high pharmacological potential.

Zitieren

APA

Latysheva, A., & Misharin, A. (2018). Steroidal Inhibitors of CYP17A1 as a Template For Novel Anti-Cancer Agents Development. Biomedical Chemistry: Research and Methods. https://doi.org/10.18097/bmcrm00020

Vancouver

Latysheva A, Misharin A. Steroidal Inhibitors of CYP17A1 as a Template For Novel Anti-Cancer Agents Development. Biomedical Chemistry: Research and Methods. 2018. doi:10.18097/bmcrm00020

BibTeX
@article{Latysheva2018,
  author = {Latysheva, A.S. and Misharin, A.Yu.},
  title = {Steroidal Inhibitors of CYP17A1 as a Template For Novel Anti-Cancer Agents Development},
  journal = {Biomedical Chemistry: Research and Methods},
  year = {2018},
  doi = {10.18097/bmcrm00020}
}
Kostenlos starten →